about
The relationship between serum levels of insulin-like growth factor-I and its binding proteins and microvascular function in acromegalic patients.Cortisol levels in cerebrospinal fluid correlate with severity and bacterial origin of meningitis.Serum preadipocyte factor-1 concentrations in females with obesity and type 2 diabetes mellitus: the influence of very low calorie diet, acute hyperinsulinemia, and fenofibrate treatment.Serum concentrations and tissue expression of components of insulin-like growth factor-axis in females with type 2 diabetes mellitus and obesity: the influence of very-low-calorie diet.The effect of very-low-calorie diet on mRNA expression of inflammation-related genes in subcutaneous adipose tissue and peripheral monocytes of obese patients with type 2 diabetes mellitus.Enhanced expressions of mRNA for neuropeptide Y and interleukin 1 beta in hypothalamic arcuate nuclei during adjuvant arthritis-induced anorexia in Lewis rats.Angiopoietin-like protein 6 in patients with obesity, type 2 diabetes mellitus, and anorexia nervosa: The influence of very low-calorie diet, bariatric surgery, and partial realimentation.Metabolomic profiling of urinary changes in mice with monosodium glutamate-induced obesity.Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration.Serum prolactin stress values in patients with systemic lupus erythematosus.Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects.The relationship between thyroid function, serum monokine induced by interferon gamma and soluble interleukin-2 receptor in thyroid autoimmune diseases.Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa.Laparoscopic sleeve gastrectomy ameliorates mRNA expression of inflammation-related genes in subcutaneous adipose tissue but not in peripheral monocytes of obese patients.Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression.Triazole GHS-R1a antagonists JMV4208 and JMV3002 attenuate food intake, body weight, and adipose tissue mass in mice.The influence of deep hypothermia on inflammatory status, tissue hypoxia and endocrine function of adipose tissue during cardiac surgery.Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus.Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance.Improvement of Insulin Sensitivity after Peroxisome Proliferator-Activated Receptor-α Agonist Treatment Is Accompanied by Paradoxical Increase of Circulating Resistin LevelsThe Peptidic GHS-R antagonist [D-Lys3]GHRP-6 markedly improves adiposity and related metabolic abnormalities in a mouse model of postmenopausal obesityElevated serum prolactin levels as a marker of inflammatory arthritis in psoriasis vulgarisExpression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitusPlasma ghrelin levels in patients with short bowel syndromeComparison of manual and automatic (MagNA Pure) isolation methods of total RNA from adipose tissue
P50
Q31097255-2DD7C344-2695-43CB-8CC8-4F35440A02DEQ36392570-7E2C5CD8-2007-4DC4-86F4-6944F9A9BB55Q38313082-145D8B22-DC85-403E-B9F1-66FC051D0F58Q38325713-EA2A6C66-98A6-4B66-8595-CA622268741BQ38337571-D6810D55-D04A-435E-8256-7C63EA1293A0Q38352196-4ECFA08C-14B7-4D10-B487-F48944F6BC39Q39803912-35D05A13-E024-4752-8043-31E9A8387FDBQ40312485-87C5F056-508D-449F-8CA1-A2AC318B7C5BQ41221501-B12CAA69-F34F-4FA3-8DA8-1C73F91C1A9EQ43050511-CF9B4C40-F833-4AE7-9AEA-726EFFE426BFQ43287114-9031F0BD-B570-4BE4-A324-FABA787DF688Q44427743-3AA8AFD2-0EDE-45BE-95B7-89D86DC8B389Q46105484-8F318B8B-7F32-4261-9EF4-9B2DF768C5ADQ46535466-4CA45A30-17FF-4805-A4BB-1EF5DDC793A2Q46680992-8C8544F8-F72F-42D3-9048-075992600B87Q46937542-AB412D69-8AE7-476E-9F9A-41FAB802E83EQ47579117-804A8D2C-9495-4B5F-9E3F-9EB731275095Q47910918-43190B57-5E36-4671-AD45-DC4A9AFFF24CQ50232434-ED6FE5D5-AE5C-48C8-81C8-6C33518DC4E6Q51149635-2064F64F-4A1A-42BA-8BA6-6CD13E0FD429Q57557806-C1DB5E91-2AA0-44D3-BC71-A536133B33B0Q61785407-0E8859ED-0286-4B9B-B85E-B0826B82F224Q62115257-89E9C516-F46B-48C5-9F6D-043EFD24ABD0Q63438331-8B56D586-3390-45A7-AFBC-95BA2B4605FAQ74438886-1316F7CB-C33A-45D4-B876-8A48EDA4E0B0Q95817587-A60D1814-F673-4B2B-BA96-42899CABA75F
P50
description
endokrinoložka, molekulární bioložka
@cs
researcher ORCID ID = 0000-0003-4916-7031
@en
wetenschapper
@nl
name
Z Lacinová
@ast
Z Lacinová
@nl
Zdeňka Lacinová
@cs
Zdeňka Lacinová
@en
Zdeňka Lacinová
@es
type
label
Z Lacinová
@ast
Z Lacinová
@nl
Zdeňka Lacinová
@cs
Zdeňka Lacinová
@en
Zdeňka Lacinová
@es
prefLabel
Z Lacinová
@ast
Z Lacinová
@nl
Zdeňka Lacinová
@cs
Zdeňka Lacinová
@en
Zdeňka Lacinová
@es
P106
P214
P1153
55889426900
P21
P214
P31
P496
0000-0003-4916-7031